Related Experiment Video
Updated: Jul 7, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions.
Pitchai Balakumar1, Tajpreet Kaur, Manjeet Singh
1I.S.F. Institute of Pharmaceutical Sciences and Drug Research, Moga 142001, Punjab, India. pbala2006@gmail.com
Vascular endothelial dysfunction (VED), linked to cardiovascular diseases, stems from factors like smoking and oxidative stress. Understanding VED mechanisms may reveal new drug targets for heart conditions.
Area of Science:
- Cardiovascular Science
- Endothelial Biology
- Vascular Physiology
Background:
- The endothelium, the inner lining of blood vessels, regulates vascular tone and plays key roles in blood flow, coagulation, and immune responses.
- Endothelial dysfunction (VED) is characterized by impaired vasodilation, inflammation, and a prothrombotic state, often driven by reduced nitric oxide and increased oxidative stress.
- Environmental factors like smoking, alcohol, and arsenic exposure contribute significantly to the development of VED, a precursor to cardiovascular disorders.
Purpose of the Study:
- To review the pathological mechanisms underlying vascular endothelial dysfunction (VED).
- To identify potential molecular targets for therapeutic intervention in VED.
- To explore novel pharmacological approaches for treating cardiovascular disorders associated with VED.
Main Methods:
- Literature review of experimental evidence and pathological mechanisms.
- Analysis of factors contributing to endothelial dysfunction.
- Identification of potential therapeutic targets based on current understanding.
Main Results:
- VED is associated with reduced nitric oxide bioavailability and heightened oxidative stress.
- Environmental factors are significant contributors to endothelial dysfunction.
- VED is a critical factor in the pathogenesis of hypertension, atherosclerosis, heart failure, myocardial infarction, and stroke.
Conclusions:
- The precise pathological mechanisms of VED require further elucidation.
- Identifying novel therapeutic targets is crucial for developing effective treatments for VED-related cardiovascular diseases.
- This review provides a foundation for exploring new pharmacological agents to address cardiovascular disorders stemming from endothelial dysfunction.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mechanism of Angiogenesis
Modified-Release Drug Delivery Systems: Site-Targeted
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
